Theratechnologies Inc. announced the appointment of Mr. Jovan Antunovic as Senior Vice President and Chief Commercial Officer. His primary mandate will be to focus on the United States market and to ensure that the company fully develop Trogarzo and EGRIFTA. Until October, Mr. Antunovic was Vice President, Specialty/Innovative Medicines Business Lead at Bristol-Myers Squibb Canada. He previously held increasingly senior positions at Abbvie, Abbott and Axcan Pharma.